10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023

NA ElSayed, G Aleppo, VR Aroda, RR Bannuru… - Diabetes …, 2023 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …

Hypertension in low-and middle-income countries

AE Schutte, N Srinivasapura Venkateshmurthy… - Circulation …, 2021 - Am Heart Assoc
In recent decades low-and middle-income countries (LMICs) have been witnessing a
significant shift toward raised blood pressure; yet in LMICs, only 1 in 3 are aware of their …

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …

G Mancia, R Kreutz, M Brunström, M Burnier… - Journal of …, 2023 - journals.lww.com
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

[HTML][HTML] Diretrizes brasileiras de hipertensão arterial–2020

WKS Barroso, CIS Rodrigues, LA Bortolotto… - Arquivos brasileiros de …, 2021 - SciELO Brasil
A hipertensão arterial (HA) é uma doença crônica não transmissível (DCNT) definida por
níveis pressóricos, em que os benefícios do tratamento (não medicamentoso e/ou …

[HTML][HTML] Brazilian guidelines of hypertension–2020

WKS Barroso, CIS Rodrigues, LA Bortolotto… - Arquivos brasileiros de …, 2021 - SciELO Brasil
SciELO - Brasil - Diretrizes Brasileiras de Hipertensão Arterial – 2020 Diretrizes Brasileiras de
Hipertensão Arterial – 2020 Acessibilidade / Reportar erro Brasil Lista alfabética de periódicos …

[HTML][HTML] Blood pressure and the new ACC/AHA hypertension guidelines

JM Flack, B Adekola - Trends in cardiovascular medicine, 2020 - Elsevier
The ACC/AHA hypertension guidelines cover virtually all aspects of the diagnosis,
evaluation, monitoring, secondary causes as well as drug and non-drug treatment of …

[HTML][HTML] Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist

FS Willard, JD Douros, MBN Gabe, AD Showalter… - JCI insight, 2020 - ncbi.nlm.nih.gov
Tirzepatide (LY3298176) is a dual GIP and GLP-1 receptor agonist under development for
the treatment of type 2 diabetes mellitus (T2DM), obesity, and nonalcoholic steatohepatitis …

[HTML][HTML] Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 …

JD Stanaway, A Afshin, E Gakidou, SS Lim, D Abate… - The Lancet, 2018 - thelancet.com
Summary Background The Global Burden of Diseases, Injuries, and Risk Factors Study
(GBD) 2017 comparative risk assessment (CRA) is a comprehensive approach to risk factor …

Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with …

CK Chow, ER Atkins, GS Hillis, MR Nelson, CM Reid… - The Lancet, 2021 - thelancet.com
Background Treatment inertia is a recognised barrier to blood pressure control, and simpler,
more effective treatment strategies are needed. We hypothesised that a hypertension …

10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2021

American Diabetes Association - Diabetes care, 2021 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Medical Care in Diabetes” includes
the ADA's current clinical practice recommendations and is intended to provide the …